| Latest Forum Topics / EFH Ltd Last:0.046 -- |
|
|
BIO PHARMA company do research on MEDICAL DISEASES
|
|||||
|
dandanb
Member |
19-Aug-2020 21:18
|
||||
|
x 0
x 0 Alert Admin |
I think should focus on how the 2.4 mil shares are granted. Jeremy is granted 1.17 million shares within two weeks from 18 Aug. The remaining of the shares are granted to Jeremy with conditions (must achieve pre-determined performance targets over performance period) and equal amount each year over 3 years  (2021 to 2023). 
|
||||
| Useful To Me Not Useful To Me | |||||
|
hotelgrand
Master |
19-Aug-2020 18:32
|
||||
|
x 0
x 0 Alert Admin |
Jeremy granted 2.4 mil share option in Biolidics on 18th Aug..see sgx | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
newbie888
Veteran |
19-Aug-2020 16:11
|
||||
|
x 0
x 0 Alert Admin |
Happily receiving free shares.. Lol
|
||||
| Useful To Me Not Useful To Me | |||||
|
guards80
Supreme |
19-Aug-2020 15:54
|
||||
|
x 0
x 0 Alert Admin |
Haha he selling
|
||||
| Useful To Me Not Useful To Me | |||||
|
Starship
Supreme |
19-Aug-2020 15:51
|
||||
|
x 0
x 0 Alert Admin |
![]()
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
ST3-trading
Senior |
19-Aug-2020 15:47
|
||||
|
x 0
x 0 Alert Admin |
what is jeremy doing. | ||||
| Useful To Me Not Useful To Me | |||||
|
newbie888
Veteran |
19-Aug-2020 12:34
|
||||
|
x 0
x 0 Alert Admin |
Ya.. And looking at the result, profit margin don't look attractive too.. Lol.. But of course hoe I'm wrong
|
||||
| Useful To Me Not Useful To Me | |||||
|
albeniz
Veteran |
19-Aug-2020 12:16
|
||||
|
x 0
x 0 Alert Admin |
Yes, should sell gloves instead. Testing kits are complicated and then worse, can end up testing wrong some more.  
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
newbie888
Veteran |
19-Aug-2020 12:13
|
||||
|
x 0
x 0 Alert Admin |
Maybe bio should switch to sell gloves instead.. Its much more simpler.. Testing kit is complicated and a mutation in the virus and all effort down the drain | ||||
| Useful To Me Not Useful To Me | |||||
|
Sunbrighten
Senior |
19-Aug-2020 11:14
|
||||
|
x 0
x 0 Alert Admin |
https://links.sgx.com/FileOpen/Announcement%20-%20Share%20Issuance%20for%20Relevant%20Persons.ashx?App=Announcement& FileID=628427
|
||||
| Useful To Me Not Useful To Me | |||||
|
Sgvale
Supreme |
19-Aug-2020 10:45
|
||||
|
x 0
x 0 Alert Admin |
Bro, u holding Biolidics? What's the target price?
|
||||
| Useful To Me Not Useful To Me | |||||
|
WBdisciple
Elite |
19-Aug-2020 08:22
|
||||
|
x 0
x 0 Alert Admin |
Pandemic has entered new phase in Asia-Pacific: WHO Nations that contained spread in early phase moving to new phase where large-scale disruptions can be minimised, it says The recent surge in cases in countries that had managed to contain the Covid-19 pandemic in its early months actually marks their move to a new phase for which they are better prepared, said a senior World Health Organisation (WHO) official. Dr Takeshi Kasai, WHO' s regional director for the Western Pacific, said at a virtual press conference yesterday: " What we are observing is not simply a resurgence. We believe it' s a signal that we' ve entered a new phase of the pandemic in the Asia-Pacific. " In this phase countries are increasingly able to minimise large-scale disruptions to people' s lives and economies." Countries such as Japan, Vietnam South Korea and Australia had moved quickly to contain Covid-19 in the early months of the pandemic, but are now fighting new surges. In some cases, the second wave is larger than the initial outbreaks, said Dr Kasai. The surge in cases is due to countries having relaxed their earlier stringent measures as they move towards reopening their economies. He said these countries " will need to deal with multiple increases or surges, but in a sustainable way" . Covid-19: Don' t miss the latest on the outbreak and its impact Stay in the know with e-mail alerts   Sign up By signing up, you agree to our Privacy Policy and Terms and Conditions. They need to have " earlier targeted response" to prevent " big disruptions to the economy and people' s life" . They should continue to improve their healthcare system and protect the vulnerable. And people in these countries need to " maintain their healthy behaviour, not just protecting themselves, but also their family, communities" , while businesses have to find ways to operate as they minimise the risk of the virus spreading. Dr Kasai said: " By combining early detection and rapid response to emerging infections, and people sticking to the prevention measures that are part of the new normal, many (countries) are now detecting outbreaks earlier and responding to them faster, with more targeted intervention." Countries planning to open up " need to continue to improve their surveillance system, and share that information" . They must come up with an agreement with the other countries that allow travel on how to manage those who are travelling, so any problems are spotted and dealt with as early as possible. This agile approach will help them to restore their health systems, societies and economies. Dr Kasai added: " The direction that the epidemic now takes depends on the actions of governments and people across the region." The WHO' s Western Pacific region includes China, Japan, South Korea, Australia, Singapore, Indonesia and the Pacific island states, among others. Asked about moves by some countries to open up for international travel, which has practically come to a standstill, Dr Kasai said countries should adopt " a risk-based approach" . They need to look at where people are travelling to and from, and the status of the outbreak in those countries. Other considerations include the kind of people who are coming into the country, and the controls or intervention that can be put in place. Dr Kasai said: " This requires continuous information sharing and assessment, and dialogue between the countries." Meanwhile, countries planning to open up " need to continue to improve their surveillance system, and share that information" . They must come up with an agreement with the other countries that allow travel on how to manage those who are travelling, so any problems are spotted and dealt with as early as possible. On the effect of mutation of the coronavirus, Dr Kasai said that based on the thousands of gene sequences available, this is a relatively stable virus, and work on a vaccine will not be affected. He said the " significant investments in health emergency preparedness made over several years" by countries in the region are paying off, and are one reason for the comparatively low Covid-19 numbers here. One lesson learnt during the pandemic is that a country' s response capacity has to be scalable, to match the size of the outbreak. Dr Kasai concluded: " Covid-19 will be with us for the foreseeable future. We know it' s a long and difficult stretch, and we will face setbacks. But we must keep trying, learning and doing it together. " How we fare is up to each and every one of us. If we make the right choices every day, we will come out of this as safe and as strong as possible." |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
WBdisciple
Elite |
19-Aug-2020 08:20
|
||||
|
x 0
x 0 Alert Admin |
Vaccine won' t be a silver bullet, experts warn A vaccine will not be a silver bullet to end the Covid-19 pandemic and the world still needs to improve its response to fight the virus. Dr Takeshi Kasai, the World Health Organisation' s (WHO) regional director for the Western Pacific, said at a virtual press conference yesterday that he is cautiously optimistic about a Covid-19 vaccine - optimistic because he is very impressed by the speed of vaccine development, and cautious because even if a safe and effective vaccine is found, production capacity is unlikely to meet global demand. One country that has been actively involved in vaccine research and development is China, which has seven vaccine candidates advancing into phase two and phase three of clinical trials. Yet, despite the accelerated speed of research and development, a panel of three WHO experts stressed the need to ensure the safety and efficacy of all vaccine candidates. The international body has been " working with a number of research and development institutes across the world, and guiding the conduct and providing protocol for vaccine clinical trials" . In other countries, such as Japan, research, development and manufacturing of vaccines are also under way. One candidate is now in stage two of clinical trials and four other candidates are in the stages of pre-clinical studies, WHO said. In terms of manufacturing, at least two companies in Japan are already discussing the transfer of technology to manufacture the vaccines once they are approved, which would help allow for quicker scaling up of vaccine production. Covid-19: Don' t miss the latest on the outbreak and its impact Stay in the know with e-mail alerts   Sign up By signing up, you agree to our Privacy Policy and Terms and Conditions. A safe and effective pandemic vaccine is a global public good that countries worldwide should have access to, the panel said at a question-and-answer segment during the press conference. The organisation called for rapid, fair and equitable access to any such vaccines globally. " We hope that the work that is ongoing in Japan and other countries in the region on research and development, and manufacturing of vaccines will benefit equally the other countries in the Western Pacific," the panel said. But ensuring fair and equitable vaccine distribution globally will not be easy, the WHO said. It noted, however, that the vaccine will not belong to a single country, but instead to all countries, as no country is safe unless all countries are protected. Initiatives will also be established to expedite the development and access for a safe and effective vaccine, and the WHO is working with countries around the world on this. When asked for the WHO' s opinion on the safety and effectiveness of Russia' s vaccine, which is ready to go into production, with the Philippines saying it is ready to receive it, the panel said the organisation is in the process of coordinating and contacting the scientists and experts, as well as the Russian regulatory authorities, to get evidence for this new vaccine. The first batch of Sputnik V - named in homage to the world' s first satellite, launched by the Soviet Union in 1957 - was developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Moscow in coordination with the Russian Defence Ministry. Russia has said industrial production is expected from next month and it plans to manufacture five million doses per month by December or next January. But a survey of 3,040 doctors and health specialists in Russia found the majority would not feel comfortable being injected with the new Covid-19 vaccine due to the lack of sufficient data about it and its super-fast approval. |
||||
| Useful To Me Not Useful To Me | |||||
|
soonsoonhuat
Veteran |
18-Aug-2020 15:33
|
||||
|
x 0
x 0 Alert Admin |
theres opportunity costs in everything u do, as for this counter, i feel that my opportunity cost is way too high already, so just cut and move to medtecs which offer me greater returns and the fundamentals of medtecs is really much superior than this anyway, now the latest test kit is using saliva, instead of serology, so i reckon, this company has lost its competiveness, until such time they develop a much more convincing product, i cease to be shareholder of this company liao. dyodd as usual |
||||
| Useful To Me Not Useful To Me | |||||
|
watashievil
Master |
18-Aug-2020 15:04
|
||||
|
x 0
x 0 Alert Admin |
It needs a good flush. else daily drop bit by bit~ alot stuck at .4 and above. any jot up will allow them to offload. drop they will sell at loss. |
||||
| Useful To Me Not Useful To Me | |||||
|
ST3-trading
Senior |
18-Aug-2020 14:44
|
||||
|
x 0
x 0 Alert Admin |
wait until old liao . 等 你 等 到 我 心 痛 | ||||
| Useful To Me Not Useful To Me | |||||
|
Mersingboy
Member |
18-Aug-2020 13:35
|
||||
|
x 0
x 0 Alert Admin |
Waiting until my neck very Long already. | ||||
| Useful To Me Not Useful To Me | |||||
|
Cadence88
Veteran |
18-Aug-2020 08:39
|
||||
|
x 0
x 0 Alert Admin |
You obviously dont know what kind of test Bio is selling.
|
||||
| Useful To Me Not Useful To Me | |||||
|
KennySP
Member |
18-Aug-2020 02:55
|
||||
|
x 0
x 0 Alert Admin |
Pilots and cabin crew on no pay leave mostly and only 10% staffs going to used this test kits.......   |
||||
| Useful To Me Not Useful To Me | |||||
|
Power1
Veteran |
17-Aug-2020 23:44
|
||||
|
x 0
x 0 Alert Admin |
Good news for Biolidics!
Pilots and cabin crew working for Singapore carriers will be tested for COVID from Aug 20 after they return from overseas. More test kit need to be use😀    
|
||||
| Useful To Me Not Useful To Me | |||||


